[e-farmacos] Current Problems in Pharmacovigilance - Mayo 2006

["Canas, Martin" <macanas@netverk.com.ar>]

Estimadas y estimados,

Despues de casi dos anhos se publica el Current Problems in Pharmacovigilance Volume 31, (Pages 1-12) May 2006

Temas:

> Topical tacrolimus (Protopic) and pimecrolimus (Elidel): potential cancer 
risk
> Duloxetine (Yentreve, Cymbalta): need for monitoring
> Tenofovir (Viread): interactions and renal adverse effects
> Linezolid (Zyvox): severe optic neuropathy
> CosmoFer and high risk of anaphylactoid reactions
> Drotrecogin alfa (activated) (Xigris): risk-benefi t in the management of 
sepsis
> Rosuvastatin (Crestor): introduction of 5 mg starting dose
> Osteonecrosis of the jaw with bisphosphonates
> High dose inhaled steroids: new advice on supply of steroid treatment 
cards
> Local reactions associated with pre-school d/DTap-IPV boosters
> Salmeterol (Serevent) and formoterol (Oxis, Foradil) in asthma management
> Risk of QT interval prolongation with methadone
> Tamsulosin (Flomax) and Intraoperative Floppy Iris Syndrome (IFIS)
> Cardiovascular safety of NSAIDs and selective COX-2 inhibitors
> Erythromycin and other macrolides: focus on interactions
> Glucosamine adverse reactions and interactions
> Isotretinoin (Roaccutane): psychiatric adverse reactions
> Cardiac arrhythmias associated with antipsychotic drugs
> HRT and tibolone (Livial): update on the risk of endometrial cancer
> Hypoglycaemia unawareness on transferring insulins
> Withdrawal of co-proxamol
> Intravenous human normal immunoglobulin (IVIg) and thromboembolic adverse 
reactions
> NSAIDs and infertility
> Patients across the UK may report suspected adverse reactions

Disponible en:
http://83.98.30.20/home/idcplg?IdcService=GET_FILE&dDocName=CON2023860&RevisionSelectionMethod=LatestReleased

Saludos,

Martin

Martin Canas
GAPURMED
La Plata 
(Argentina)
macanas@netverk.com.ar